Products | Focused Ultrasound Therapy | June 19, 2018

Focal One

Focal One

Related Content

A Brigham and Women’s Hospital study of 30 people found that, in patients with MS, advanced brain imaging could identify hidden inflammation not picked up on traditional MRIs
News | PET Imaging
PET Scans Reveal ‘Smoldering’ Inflammation in Patients with Multiple Sclerosis

April 24, 2024 — A new study from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare ...

Time April 24, 2024
arrow
The International Contrast Ultrasound Society (ICUS) and Northwest Imaging Forums (NWIF) today announced an educational partnership to help train sonographers to perform contrast-enhanced ultrasound (CEUS) examinations and administer intravenous ultrasound contrast agents
News | Contrast Media
International Contrast Ultrasound Society (ICUS) and Northwest Imaging Forums Announce Partnership to Advance IV Training for Sonographers

April 24, 2024 — The International Contrast Ultrasound Society (ICUS) and Northwest Imaging Forums (NWIF) announced an ...

Time April 24, 2024
arrow
A diverse writing group—lead by authors at the University of Toronto—have developed an approach for radiology departments and practices to reduce their greenhouse gas emissions
News | Radiology Business
Radiologists Propose Actions to Combat Climate Change

April 23, 2024 — A diverse writing group—lead by authors at the University of Toronto—have developed an approach for ...

Time April 23, 2024
arrow
Vista.ai appoints MedTech veteran Daniel Hawkins President and
News | Radiology Business
Vista.ai Appoints MedTech Veteran Daniel Hawkins as Chief Executive Officer

April 17, 2024 — VISTA.AI announced the appointment of Daniel Hawkins as President and CEO. The company is pioneering AI ...

Time April 17, 2024
arrow
new 3-part video series on advancements in diagnostic radiology with Robert L. Bard, MD, PC, DABR, FASLMS
Feature | Radiation Oncology | By Melinda Taschetta-Millane
Advancements in Diagnostic Radiology Video Series with Robert L. Bard, MD, PC, DABR, FASLMS

In a new 3-part video series on advancements in diagnostic radiology with Robert L. Bard, MD, PC, DABR, FASLMS ...

Time April 10, 2024
arrow
Magnetic resonance-guided focused ultrasound (MRgFUS) is a non-invasive technique for neuroregulation
News | Magnetic Resonance Imaging (MRI)
Magnetic Resonance-guided Focused Ultrasound in Intracranial Diseases

April 8, 2024 — Magnetic resonance-guided focused ultrasound (MRgFUS) is a non-invasive technique for neuroregulation ...

Time April 08, 2024
arrow
Collaboration set to deliver comprehensive navigation and imaging integration that will streamline intraoperative decision-making
News | Radiology Business
Brainlab and Fujifilm Integrate Cutting-Edge Technology, Offering Advanced Capabilities to Neurosurgery Clinicians in the US

April 4, 2024 — FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging ...

Time April 04, 2024
arrow
Ultrasound (US) images in a 57-year-old female patient with multifocal papillary thyroid carcinoma (PTC).
News | Radiation Oncology
Minimally Invasive Procedure May Spare Patients from Thyroid Surgery

April 2, 2024 — In a 10-center study, microwave ablation offered progression free survival rates and fewer complications ...

Time April 02, 2024
arrow
During the blood pool phase, it significantly shortens the T1 and T2 relaxation times of the blood, thus achieving bright blood effects in T1-weighted imaging and dark blood effects in T2/T2*-weighted imaging. In the delay phase, by the local aggregation of ferumoxytol disrupting the uniformity of the local magnetic field, the decrease of the transverse magnetization vector Mxy is expedited, resulting in a negative contrast effect.
News | Molecular Imaging
Exploring Ferumoxytol: A Frontier in MRI Contrast Agents

March 29, 2024 — Magnetic resonance imaging (MRI) is a cornerstone in the landscape of medical diagnostics, celebrated ...

Time March 29, 2024
arrow
SyntheticMR announced today that their next-generation imaging solution with isotropic resolution, SyMRI 3D, has received FDA 510(k) clearance for clinical use in the United States
News | FDA
SyntheticMR Receives FDA 510(k) Clearance for its Next Generation Solution SyMRI 3D

March 27, 2024 — SyntheticMR announced that its next-generation imaging solution, SyMRI 3D, has received FDA 510(k) ...

Time March 27, 2024
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now